Metabolomics Market Size, Share & Industry Analysis, By Offering (Products {Instruments and Consumables}, Software, and Services), By Technique (Liquid Chromatography-Mass Spectrometry (LC-MS), Gas Chromatography-Mass Spectrometry (GC-MS), Nuclear Magnetic Resonance Spectroscopy (NMR), and Others), By Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, & Others), By Disease Indication (Cancer, Cardiovascular Diseases, Neurological Disorders, & Others), By End User (Pharmaceutical and Biotechnology Companies, CROs / CMOs, & Others), and Regional Forecast, 2026-2034

Last Updated: March 03, 2026 | Format: PDF | Report ID: FBI115625

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 12.07% from 2026-2034
Unit	Value (USD Billion)
Segmentation	By Offering, Technique, Application, Disease Indication, End User, and Region
By Offering	Products Instruments Consumables Software Services
By Technique	Liquid Chromatography-Mass Spectrometry (LC-MS) Gas Chromatography-Mass Spectrometry (GC-MS) Nuclear Magnetic Resonance Spectroscopy (NMR) Others
By Application	Biomarker Discovery Drug Discovery Toxicology Testing Precision Medicine Others
By Disease Indication	Cancer Cardiovascular Diseases Neurological Disorders Metabolic Disorders Others
By End User	Pharmaceutical and Biotechnology Companies CROs / CMOs Academic & Research Institutes Diagnostic Labs Others
By Region	North America (By Offering, Technique, Application, Disease Indication, End User, and Country) U.S. Canada Europe (By Offering, Technique, Application, Disease Indication, End User, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Offering, Technique, Application, Disease Indication, End User, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Offering, Technique, Application, Disease Indication, End User, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Offering, Technique, Application, Disease Indication, End User, and Country/Sub-region) GCC South Africa Rest of the Middle East & Africa